Tumor Markers

Point-of-care rapid testing for tumor markers. OEM/ODM manufacturer.

Overview

Tumor markers are proteins associated with certain cancers, used in screening support and monitoring of high-risk groups.

Clinical Context

Tumor markers are proteins associated with certain cancers, used in screening support and monitoring, not standalone diagnosis.

Diagnostic Markers & Methods

PSA (prostate) · AFP (hepatocellular) · CEA (colorectal) · CA-series.

Antigen vs Antibody

Tumor-marker tests detect proteins (antigens); some autoimmune serology (RF) uses antibody detection.

Diagnostic Workflow

Elevated marker (PSA/AFP/CEA) → imaging + biopsy → confirmed diagnosis → serial monitoring.

Testing Window

Not time-critical; used in screening support and serial monitoring.

Interpretation

Elevated tumor markers are not diagnostic of cancer — imaging and confirmatory testing are required; markers also rise in benign conditions.

False Negative / Positive Considerations

False negative: non-secreting tumors. False positive: markers also rise in benign conditions.

Confirmatory Testing

Imaging and biopsy; markers are not diagnostic alone.

Testing Settings

Screening support and monitoring in clinics and labs; imaging/biopsy are definitive.

Sources

NCCN guidelines; national cancer-screening recommendations.

Progene's Take

Position: Sell tumor markers as monitoring aids, never as standalone cancer tests — the honest framing is the only sustainable one.

  • PSA/AFP/CEA rise in benign conditions too; imaging and confirmatory testing are required.
  • Overclaiming a cancer-screening use creates regulatory and reputational risk.
  • High-risk surveillance and monitoring are the legitimate, defensible use cases.

This is the buyer-advisor view of the technical team — editorial guidance, not a substitute for product IFU or local regulatory requirements.

Frequently Asked Questions

Can a tumor marker rapid test diagnose cancer?

No — PSA, AFP and CEA rise in benign conditions too, and confirmation requires imaging and other testing. They are monitoring/screening-support aids.

What is PSA used for?

Prostate cancer screening support and monitoring; elevated PSA prompts further evaluation (biopsy), but is not cancer-specific.

What is AFP associated with?

Hepatocellular carcinoma (liver cancer) — used in high-risk surveillance and monitoring, alongside imaging.

Products (3)

Need a full Tumor Markers testing panel? Request datasheets, IFU and OEM/ODM options.